11400sek
0,3 %
Date:2026-10-02Time:18:00:00Latest report:Q2-2026List:Mid CapTicker:BIOG B
Market Cap:11 532 msekEnterprise Value:11 086 msekNet Sales:1 581 msekEarnings:347,2 msekEmployees:0ISIN:SE0017769995
Ratios
10-year key figure history for BioGaia turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for BioGaia with index and moving average MA50 and MA200.
Stockprice:114,00
MA50:112,96
MA200:115,02
Price/MA200:-0,9 %
RSI (14):55,0
Price/MA50:0,9 %
Description
BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.